Aug. 9 (UPI) --The U.S. Food and Drug Administration on Friday announced the approval of the first nasal spray for treatment of anaphylaxis, a life-threatening allergic reaction. The epinephrine nasal ...
Please provide your email address to receive an email when new articles are posted on . Fears associated with needles may cause patients and caregivers to delay their use of epinephrine autoinjectors.
The U.S. Food and Drug Administration approved a new nasal spray on Friday to treat emergency allergic reactions in adults and children — the first injection-free alternative to shots like EpiPen. The ...
Please provide your email address to receive an email when new articles are posted on . Intranasal spray had faster and higher maximum concentrations than autoinjectors and manual syringes. The spray ...
The FDA has approved a nasal spray, neffy, as the first non-needle means of delivering rescue epinephrine during anaphylaxis The spray is meant for adults and kids weighing over 66 pounds FRIDAY, Aug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results